Learn more
Log in
0 followers
Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.
Industries
Headquarters
Stage
Employees
Links
James McCullough
14 members
8 members
3 members
5 members
4 members
SpringWorks Therapeutics
2 followers
Quantum-Si
1 follower
Viridian Therapeutics
BioLabs
Akoya Biosciences
Discover companies